FDA Inspection
Janssen Biotech Inc.Janssen Biotech Inc. – FDA Inspection, Apr 14, 2011
Record Details
This FDA Inspection record concerns Janssen Biotech Inc., with an inspection on April 14, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Janssen Biotech Inc.
- Inspection Date
- April 14, 2011
- Product Type
- Drugs
View Company Profile
ID · b5041907-852a-4c3f-9afb-b7f50fe7a765
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 717037
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.198(a)Complaint Handling Procedure
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Janssen Biotech Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 17, 2025 | Not classified | Philadelphia District Office | |
| September 24, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 22, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 25, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 24, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Janssen Biotech Inc.
- FDA Inspection 1255317 - 2025-01-17
- FDA Inspection 1251380 - 2024-09-24
- FDA Inspection 1057464 - 2018-06-22
- FDA Inspection 963728 - 2016-02-25
- FDA Inspection 954726 - 2015-11-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.